Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
American Academy of Neurology to hold a virtual meeting » 09:24
04/19/21
04/19
09:24
04/19/21
09:24
ABBV

AbbVie

$107.93 /

+1.05 (+0.98%)

, ABC

AmerisourceBergen

$119.62 /

+0.55 (+0.46%)

, ABT

Abbott

$124.37 /

+0.4 (+0.32%)

, ACAD

Acadia Pharmaceuticals

$21.17 /

-0.02 (-0.09%)

, ALNY

Alnylam

$138.69 /

-0.23 (-0.17%)

, BIIB

Biogen

$270.07 /

-0.66 (-0.24%)

, BMY

Bristol-Myers

$65.46 /

+1.02 (+1.58%)

, BHVN

Biohaven Pharmaceutical

$74.37 /

-1.435 (-1.89%)

, CPRX

Catalyst Pharmaceuticals

$4.44 /

-0.02 (-0.45%)

, DGX

Quest Diagnostics

$130.09 /

+0.86 (+0.67%)

, DNA

Bought by RHHBY

$94.97 /

+ (+0.00%)

, HZNP

Horizon Therapeutics

$93.25 /

-0.32 (-0.34%)

, LIVN

LivaNova

$81.37 /

-1.46 (-1.76%)

, LLY

Eli Lilly

$189.25 /

+3.28 (+1.76%)

, MDT

Medtronic

$125.91 /

+0.06 (+0.05%)

, NVS

Novartis

$88.02 /

+0.81 (+0.93%)

, NVTA

Invitae

$37.65 /

-1.47 (-3.76%)

, PFE

Pfizer

$38.57 /

+0.96 (+2.55%)

, PTCT

PTC Therapeutics

$48.48 /

+0.33 (+0.69%)

, RETA

Reata Pharmaceuticals

$90.83 /

-1.29 (-1.40%)

, SNY

Sanofi

$51.29 /

+0.63 (+1.24%)

, SUPN

Supernus

$31.72 /

-0.09 (-0.28%)

, TAK

Takeda Pharmaceutical

$17.08 /

-0.13 (-0.76%)

, TEVA

Teva

$10.75 /

-0.08 (-0.74%)

, TGTX

TG Therapeutics

$44.79 /

-1.05 (-2.29%)

, ZGNX

Zogenix

$19.00 /

-0.65 (-3.31%)

, AVDL

Avadel Pharmaceuticals

$8.65 /

+0.09 (+1.05%)

, JNJ

Johnson & Johnson

$162.24 /

+1.74 (+1.08%)

73rd Annual Virtual…

73rd Annual Virtual Meeting of AAN will be held on April 17-22. Webcast Link

ShowHide Related Items >><<
ZGNX Zogenix
$19.00 /

-0.65 (-3.31%)

TGTX TG Therapeutics
$44.79 /

-1.05 (-2.29%)

TEVA Teva
$10.75 /

-0.08 (-0.74%)

TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

SUPN Supernus
$31.72 /

-0.09 (-0.28%)

SNY Sanofi
$51.29 /

+0.63 (+1.24%)

RETA Reata Pharmaceuticals
$90.83 /

-1.29 (-1.40%)

PTCT PTC Therapeutics
$48.48 /

+0.33 (+0.69%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

NVTA Invitae
$37.65 /

-1.47 (-3.76%)

NVS Novartis
$88.02 /

+0.81 (+0.93%)

MDT Medtronic
$125.91 /

+0.06 (+0.05%)

LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

LIVN LivaNova
$81.37 /

-1.46 (-1.76%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

HZNP Horizon Therapeutics
$93.25 /

-0.32 (-0.34%)

DGX Quest Diagnostics
$130.09 /

+0.86 (+0.67%)

CPRX Catalyst Pharmaceuticals
$4.44 /

-0.02 (-0.45%)

BMY Bristol-Myers
$65.46 /

+1.02 (+1.58%)

BIIB Biogen
$270.07 /

-0.66 (-0.24%)

BHVN Biohaven Pharmaceutical
$74.37 /

-1.435 (-1.89%)

AVDL Avadel Pharmaceuticals
$8.65 /

+0.09 (+1.05%)

ALNY Alnylam
$138.69 /

-0.23 (-0.17%)

ACAD Acadia Pharmaceuticals
$21.17 /

-0.02 (-0.09%)

ABT Abbott
$124.37 /

+0.4 (+0.32%)

ABC AmerisourceBergen
$119.62 /

+0.55 (+0.46%)

ABBV AbbVie
$107.93 /

+1.05 (+0.98%)

ABBV AbbVie
$107.93 /

+1.05 (+0.98%)

04/06/21 RBC Capital
AbbVie transferred with an Outperform at RBC Capital
04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
04/01/21 Piper Sandler
Piper migraine survey bearish for Amgen, bullish for Biohaven
03/17/21 JPMorgan
AbbVie selloff on Rinvoq deal 'appears overdone,' says JPMorgan
ABC AmerisourceBergen
$119.62 /

+0.55 (+0.46%)

03/09/21 Baird
AmerisourceBergen remains top pick following results, says Baird
02/09/21 Mizuho
AmerisourceBergen price target raised to $114 from $104 at Mizuho
02/08/21 Cowen
AmerisourceBergen price target raised to $150 from $145 at Cowen
02/04/21 Evercore ISI
AmerisourceBergen upgraded to Outperform after Q1 report at Evercore ISI
ABT Abbott
$124.37 /

+0.4 (+0.32%)

04/15/21 Atlantic Equities
Atlantic Equities starts Abbott at Neutral
04/15/21 Atlantic Equities
Abbott initiated with a Neutral at Atlantic Equities
03/16/21 Piper Sandler
Abbott study challenging Abiomed's Impella halted, says Piper Sandler
03/10/21 Wells Fargo
Wells says Quidel Covid testing comments not a direct read through to Abbott
ACAD Acadia Pharmaceuticals
$21.17 /

-0.02 (-0.09%)

04/07/21 Needham
Acadia price target lowered to $30 from $44 at Needham
04/07/21 H.C. Wainwright
Acadia downgraded to Neutral from Buy at H.C. Wainwright
04/06/21 SVB Leerink
Acadia price target lowered to $31 from $63 at SVB Leerink
04/06/21 Jefferies
Acadia downgraded to Hold at Jefferies after dementia-related psychosis CRL
ALNY Alnylam
$138.69 /

-0.23 (-0.17%)

02/22/21 Guggenheim
Alnylam downgraded to Neutral from Buy at Guggenheim
02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 Barclays
Alnylam price target raised to $196 from $162 at Barclays
02/12/21 Citi
Alnylam downgraded to Neutral from Buy at Citi
BIIB Biogen
$270.07 /

-0.66 (-0.24%)

04/13/21 Roth Capital
Roth Capital sees Applied Genetic's XLRS licensing as vote of confidence
04/12/21 Oppenheimer
Sage Therapeutics data support 'enthusiasm' for SAGE-324 in ET, says Oppenheimer
04/12/21 Wedbush
Biogen price target raised to $245 from $236 at Wedbush
03/25/21 Piper Sandler
Piper says Biogen Tecfidera patents could change thesis, but sees unknowns
BMY Bristol-Myers
$65.46 /

+1.02 (+1.58%)

04/13/21 Truist
Bristol-Myers upgraded to Buy at Truist on improving pipeline asset visibility
04/13/21 Truist
Bristol-Myers upgraded to Buy from Hold at Truist
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/08/21 BofA
Gartner added to US 1 List, Bristol-Myers removed at BofA
BHVN Biohaven Pharmaceutical
$74.37 /

-1.435 (-1.89%)

03/11/21
Fly Intel: Top five analyst initiations
03/11/21 UBS
Biohaven Pharmaceutical initiated with a Buy at UBS
03/02/21 Mizuho
Biohaven Pharmaceutical price target raised to $103 from $93 at Mizuho
CPRX Catalyst Pharmaceuticals
$4.44 /

-0.02 (-0.45%)

03/16/21 Piper Sandler
Catalyst business continues to generate cash flow, says Piper Sandler
01/07/21 Piper Sandler
Piper says Catalyst's Firdapse commercial business performing as expected
01/06/21 Piper Sandler
Catalyst Firdapse commercial business performing as expected, says Piper Sandler
11/10/20 Piper Sandler
Catalyst Pharmaceuticals price target lowered to $5.50 from $6 at Piper Sandler
DGX Quest Diagnostics
$130.09 /

+0.86 (+0.67%)

03/12/21 Baird
Quest Diagnostics downgraded to Neutral from Outperform at Baird
01/29/21 Citi
Quest Diagnostics price target raised to $158 from $151 at Citi
12/17/20 Morgan Stanley
Morgan Stanley cuts Quest Diagnostics to Equal Weight ahead of 2022 slowdown
12/17/20 Morgan Stanley
Quest Diagnostics downgraded to Equal Weight from Overweight at Morgan Stanley
DNA Bought by RHHBY
$94.97 /

+ (+0.00%)

HZNP Horizon Therapeutics
$93.25 /

-0.32 (-0.34%)

03/25/21 Guggenheim
Horizon Therapeutics price target raised to $120 from $115 at Guggenheim
03/22/21
Fly Intel: Top five analyst initiations
03/22/21 Morgan Stanley
Horizon Therapeutics resumed with an Overweight at Morgan Stanley
03/18/21 Citi
Horizon Therapeutics price target raised to $120 from $116 at Citi
LIVN LivaNova
$81.37 /

-1.46 (-1.76%)

04/13/21 Piper Sandler
LivaNova price target raised to $92 from $81 at Piper Sandler
03/03/21
Fly Intel: Top five analyst downgrades
03/03/21 Berenberg
Berenberg cuts LivaNova EPS forecasts on investments, downgrades to Hold
03/03/21 Berenberg
LivaNova downgraded to Hold from Buy at Berenberg
LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

04/12/21 Benchmark
Benchmark sees full FDA approval of Regeneron's REGEN-COV coming
04/06/21 JPMorgan
JPMorgan survey 'broadly positive' on Eli Lilly Alzheimer's drug
03/24/21 BMO Capital
AbCellera price target lowered to $59 from $61 at BMO Capital
03/17/21 Mizuho
AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho
MDT Medtronic
$125.91 /

+0.06 (+0.05%)

04/15/21 Atlantic Equities
Atlantic Equities starts Medtronic at Overweight
04/15/21 Atlantic Equities
Medtronic initiated with an Overweight at Atlantic Equities
04/05/21 Citi
Citi opens positive catalyst watches on four medical supply stocks
02/24/21 Cowen
Medtronic price target raised to $135 from $120 at Cowen
NVS Novartis
$88.02 /

+0.81 (+0.93%)

04/05/21 Morgan Stanley
Regenxbio AAV9 patent challenged by Passage Bio, says Morgan Stanley
03/23/21 Societe Generale
Novartis price target raised to CHF 107 from CHF 104 at Societe Generale
03/22/21 Bernstein
Novartis initiated with a Market Perform at Bernstein
03/10/21
Fly Intel: Top five analyst downgrades
NVTA Invitae
$37.65 /

-1.47 (-3.76%)

04/05/21 Oppenheimer
Oppenheimer upgrades Invitae on valuation, sees potential high $50s stock
04/05/21 Oppenheimer
Invitae upgraded to Outperform from Perform at Oppenheimer
02/18/21 Ladenburg
Invitae upgraded to Buy with $58 price target at Ladenburg
02/18/21 Ladenburg
Invitae upgraded to Buy from Neutral at Ladenburg
PFE Pfizer
$38.57 /

+0.96 (+2.55%)

04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
04/09/21
Pfizer to host conference call
04/06/21 RBC Capital
Pfizer transferred with a Sector Perform at RBC Capital
PTCT PTC Therapeutics
$48.48 /

+0.33 (+0.69%)

03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform from Underperform at RBC Capital
02/26/21 Cantor Fitzgerald
PTC Therapeutics price target lowered to $75 from $81 at Cantor Fitzgerald
02/12/21 BofA
PTC Therapeutics downgraded to Neutral from Buy at BofA
RETA Reata Pharmaceuticals
$90.83 /

-1.29 (-1.40%)

11/25/20 Citi
Reata Pharmaceuticals price target lowered to $234 from $260 at Citi
11/10/20 Cantor Fitzgerald
Reata Pharmaceuticals price target raised to $220 from $169 at Cantor Fitzgerald
11/10/20 Citi
Reata Pharmaceuticals price target raised to $260 from $244 at Citi
08/11/20 Cantor Fitzgerald
Reata Pharmaceuticals price target lowered to $169 from $275 at Cantor Fitzgerald
SNY Sanofi
$51.29 /

+0.63 (+1.24%)

04/06/21 Barclays
Sanofi price target raised to EUR 85 from EUR 80 at Barclays
02/23/21 BofA
BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list
02/10/21 Morgan Stanley
Sanofi price target raised to EUR 104 from EUR 101 at Morgan Stanley
02/05/21 Piper Sandler
Piper reiterates Overweight on Kymera after Sanofi capital markets day
SUPN Supernus
$31.72 /

-0.09 (-0.28%)

04/13/21 Jefferies
Supernus upgraded to Buy after survey work at Jefferies
04/13/21 Jefferies
Supernus upgraded to Buy from Hold at Jefferies
02/03/21 Piper Sandler
Supernus price target raised to $35 from $30 at Piper Sandler
06/16/20 Piper Sandler
Supernus upgraded to Overweight from Neutral at Piper Sandler
TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

09:04 Today JPMorgan
Takeda Pharmaceutical downgraded to Neutral on R&D investments at JPMorgan
09:00 Today JPMorgan
Takeda Pharmaceutical downgraded to Neutral from Overweight at JPMorgan
04/15/21 Oppenheimer
Molecular Templates price target lowered to $13 from $18 at Oppenheimer
04/05/21
Fly Intel: Top five analyst downgrades
TEVA Teva
$10.75 /

-0.08 (-0.74%)

04/06/21 RBC Capital
Teva transferred with a Sector Perform at RBC Capital
01/26/21 Piper Sandler
Amarin in 'strong position' against Health Net, says Piper Sandler
12/21/20 Gabelli
Teva named 'Best Idea for 2021' at Gabelli
11/27/20 H.C. Wainwright
Corcept Therapeutics price target raised to $32 from $22 at H.C. Wainwright
TGTX TG Therapeutics
$44.79 /

-1.05 (-2.29%)

07:12 Today Cantor Fitzgerald
TG Therapeutics price target raised to $74 from $68 at Cantor Fitzgerald
06:14 Today H.C. Wainwright
TG Therapeutics price target raised to $89 from $79 at H.C. Wainwright
03/04/21 B. Riley
TG Therapeutics price target lowered to $91 from $95 at B. Riley Securities
02/09/21 B. Riley
TG Therapeutics price target raised to $95 from $90 at B. Riley Securities
ZGNX Zogenix
$19.00 /

-0.65 (-3.31%)

04/06/21 Evercore ISI
Evercore starts 'compelling' Arena spinoff Longboard at Outperform
04/06/21 Citi
Longboard Pharmaceuticals initiated with a Buy at Citi
02/03/21 Mizuho
Jazz deal for GW Pharma has positive read through to Zogenix, says Mizuho
12/04/20 Mizuho
Zogenix collaboration step in right direction, says Mizuho
AVDL Avadel Pharmaceuticals
$8.65 /

+0.09 (+1.05%)

03/10/21 H.C. Wainwright
Avadel Pharmaceuticals price target raised to $17 from $15 at H.C. Wainwright
01/25/21 Craig-Hallum
Avadel Pharmaceuticals assumed with a Buy rating at Craig-Hallum
08/28/20 Oppenheimer
Uwarranted pressure creates buying opportunity for Avadel, says Oppenheimer
08/28/20 SVB Leerink
Avadel selloff on Jazz competition worries overdone, says SVB Leerink
JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

09:14 Today Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
ZGNX Zogenix
$19.00 /

-0.65 (-3.31%)

TGTX TG Therapeutics
$44.79 /

-1.05 (-2.29%)

TEVA Teva
$10.75 /

-0.08 (-0.74%)

TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

SUPN Supernus
$31.72 /

-0.09 (-0.28%)

SNY Sanofi
$51.29 /

+0.63 (+1.24%)

RETA Reata Pharmaceuticals
$90.83 /

-1.29 (-1.40%)

PTCT PTC Therapeutics
$48.48 /

+0.33 (+0.69%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

NVTA Invitae
$37.65 /

-1.47 (-3.76%)

NVS Novartis
$88.02 /

+0.81 (+0.93%)

MDT Medtronic
$125.91 /

+0.06 (+0.05%)

LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

LIVN LivaNova
$81.37 /

-1.46 (-1.76%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

HZNP Horizon Therapeutics
$93.25 /

-0.32 (-0.34%)

DGX Quest Diagnostics
$130.09 /

+0.86 (+0.67%)

CPRX Catalyst Pharmaceuticals
$4.44 /

-0.02 (-0.45%)

BMY Bristol-Myers
$65.46 /

+1.02 (+1.58%)

BIIB Biogen
$270.07 /

-0.66 (-0.24%)

BHVN Biohaven Pharmaceutical
$74.37 /

-1.435 (-1.89%)

AVDL Avadel Pharmaceuticals
$8.65 /

+0.09 (+1.05%)

ALNY Alnylam
$138.69 /

-0.23 (-0.17%)

ACAD Acadia Pharmaceuticals
$21.17 /

-0.02 (-0.09%)

ABT Abbott
$124.37 /

+0.4 (+0.32%)

ABC AmerisourceBergen
$119.62 /

+0.55 (+0.46%)

ABBV AbbVie
$107.93 /

+1.05 (+0.98%)

  • 16
    Mar
  • 22
    Jan
  • 15
    Dec
  • 02
    Dec
  • 07
    Aug
  • 15
    May
  • 29
    Apr
TEVA Teva
$10.75 /

-0.08 (-0.74%)

SNY Sanofi
$51.29 /

+0.63 (+1.24%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

NVS Novartis
$88.02 /

+0.81 (+0.93%)

LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

LIVN LivaNova
$81.37 /

-1.46 (-1.76%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

BMY Bristol-Myers
$65.46 /

+1.02 (+1.58%)

BIIB Biogen
$270.07 /

-0.66 (-0.24%)

ALNY Alnylam
$138.69 /

-0.23 (-0.17%)

ABT Abbott
$124.37 /

+0.4 (+0.32%)

ABC AmerisourceBergen
$119.62 /

+0.55 (+0.46%)

ABBV AbbVie
$107.93 /

+1.05 (+0.98%)

ZGNX Zogenix
$19.00 /

-0.65 (-3.31%)

TGTX TG Therapeutics
$44.79 /

-1.05 (-2.29%)

TEVA Teva
$10.75 /

-0.08 (-0.74%)

TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

SUPN Supernus
$31.72 /

-0.09 (-0.28%)

SNY Sanofi
$51.29 /

+0.63 (+1.24%)

RETA Reata Pharmaceuticals
$90.83 /

-1.29 (-1.40%)

PTCT PTC Therapeutics
$48.48 /

+0.33 (+0.69%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

NVTA Invitae
$37.65 /

-1.47 (-3.76%)

NVS Novartis
$88.02 /

+0.81 (+0.93%)

LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

HZNP Horizon Therapeutics
$93.25 /

-0.32 (-0.34%)

DGX Quest Diagnostics
$130.09 /

+0.86 (+0.67%)

CPRX Catalyst Pharmaceuticals
$4.44 /

-0.02 (-0.45%)

BMY Bristol-Myers
$65.46 /

+1.02 (+1.58%)

BIIB Biogen
$270.07 /

-0.66 (-0.24%)

BHVN Biohaven Pharmaceutical
$74.37 /

-1.435 (-1.89%)

AVDL Avadel Pharmaceuticals
$8.65 /

+0.09 (+1.05%)

ACAD Acadia Pharmaceuticals
$21.17 /

-0.02 (-0.09%)

ABT Abbott
$124.37 /

+0.4 (+0.32%)

ABC AmerisourceBergen
$119.62 /

+0.55 (+0.46%)

ABBV AbbVie
$107.93 /

+1.05 (+0.98%)

ZGNX Zogenix
$19.00 /

-0.65 (-3.31%)

TGTX TG Therapeutics
$44.79 /

-1.05 (-2.29%)

TEVA Teva
$10.75 /

-0.08 (-0.74%)

TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

NVTA Invitae
$37.65 /

-1.47 (-3.76%)

MDT Medtronic
$125.91 /

+0.06 (+0.05%)

LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

HZNP Horizon Therapeutics
$93.25 /

-0.32 (-0.34%)

DGX Quest Diagnostics
$130.09 /

+0.86 (+0.67%)

BMY Bristol-Myers
$65.46 /

+1.02 (+1.58%)

BIIB Biogen
$270.07 /

-0.66 (-0.24%)

ABT Abbott
$124.37 /

+0.4 (+0.32%)

ABC AmerisourceBergen
$119.62 /

+0.55 (+0.46%)

ABBV AbbVie
$107.93 /

+1.05 (+0.98%)

Downgrade
Takeda Pharmaceutical downgraded to Neutral on R&D investments at JPMorgan » 09:04
04/19/21
04/19
09:04
04/19/21
09:04
TAK

Takeda Pharmaceutical

$17.08 /

-0.13 (-0.76%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

09:00 Today JPMorgan
Takeda Pharmaceutical downgraded to Neutral from Overweight at JPMorgan
04/15/21 Oppenheimer
Molecular Templates price target lowered to $13 from $18 at Oppenheimer
04/05/21
Fly Intel: Top five analyst downgrades
04/05/21 Barclays
Molecular Templates MT-3724 discontinuation shouldn't be surprise, says Barclays
TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

Downgrade
Takeda Pharmaceutical downgraded to Neutral from Overweight at JPMorgan » 09:00
04/19/21
04/19
09:00
04/19/21
09:00
TAK

Takeda Pharmaceutical

$17.08 /

-0.13 (-0.76%)

JPMorgan analyst Seiji…

JPMorgan analyst Seiji Wakao downgraded Takeda Pharmaceutical to Neutral from Overweight with a 4,200 yen price target.

ShowHide Related Items >><<
TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

04/15/21 Oppenheimer
Molecular Templates price target lowered to $13 from $18 at Oppenheimer
04/05/21
Fly Intel: Top five analyst downgrades
04/05/21 Barclays
Molecular Templates MT-3724 discontinuation shouldn't be surprise, says Barclays
04/05/21 Jefferies
Takeda Pharmaceutical downgraded to Hold from Buy at Jefferies
TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

Recommendations
Las Vegas Sands price target raised to $71 from $66 at Jefferies » 08:50
04/19/21
04/19
08:50
04/19/21
08:50
LVS

Las Vegas Sands

$61.00 /

-0.3 (-0.49%)

Jefferies analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LVS Las Vegas Sands
$61.00 /

-0.3 (-0.49%)

LVS Las Vegas Sands
$61.00 /

-0.3 (-0.49%)

04/07/21 Truist
Truist sees NY budget agreement's mobile sports betting deal as 'clear as mud'
04/06/21 Credit Suisse
Reports, contacts point to sports betting momentum in NY, Credit Suisse says
03/29/21 Deutsche Bank
New York may be 'kicking the can' on sports betting, says Deutsche
03/18/21 JPMorgan
Micro-betting market in U.S. 'could be substantial,' says JPMorgan
LVS Las Vegas Sands
$61.00 /

-0.3 (-0.49%)

LVS Las Vegas Sands
$61.00 /

-0.3 (-0.49%)

LVS Las Vegas Sands
$61.00 /

-0.3 (-0.49%)

LVS Las Vegas Sands
$61.00 /

-0.3 (-0.49%)

Hot Stocks
Ovid Therapeutics to discontinue development of OV101 » 08:03
04/19/21
04/19
08:03
04/19/21
08:03
OVID

Ovid Therapeutics

$3.79 /

-0.025 (-0.66%)

, TAK

Takeda Pharmaceutical

$17.08 /

-0.13 (-0.76%)

Ovid Therapeutics (OVID)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

OVID Ovid Therapeutics
$3.79 /

-0.025 (-0.66%)

OVID Ovid Therapeutics
$3.79 /

-0.025 (-0.66%)

03/04/21 Citi
Ovid Therapeutics price target raised to $5 from $4 at Citi
03/03/21 RBC Capital
Ovid downgraded to Sector Perform at RBC Capital after rally on Takeda deal
03/03/21 RBC Capital
Ovid Therapeutics downgraded to Sector Perform from Outperform at RBC Capital
12/02/20 RBC Capital
Ovid Therapeutics price target lowered to $5 from $17 at RBC Capital
TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

04/15/21 Oppenheimer
Molecular Templates price target lowered to $13 from $18 at Oppenheimer
04/05/21
Fly Intel: Top five analyst downgrades
04/05/21 Barclays
Molecular Templates MT-3724 discontinuation shouldn't be surprise, says Barclays
04/05/21 Jefferies
Takeda Pharmaceutical downgraded to Hold from Buy at Jefferies
TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

OVID Ovid Therapeutics
$3.79 /

-0.025 (-0.66%)

  • 25
    Aug
OVID Ovid Therapeutics
$3.79 /

-0.025 (-0.66%)

TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

OVID Ovid Therapeutics
$3.79 /

-0.025 (-0.66%)

Yesterday
Downgrade
OneMain Holdings downgraded to Market Perform from Outperform at BMO Capital » 19:36
04/18/21
04/18
19:36
04/18/21
19:36
OMF

OneMain Holdings

$55.96 /

+0.73 (+1.32%)

, KKR

KKR

$53.29 /

+0.36 (+0.68%)

, APO

Apollo Global

$51.54 /

+1.27 (+2.53%)

, BEN

Franklin Resources

$30.05 /

-0.24 (-0.79%)

, VCTR

Victory Capital

$27.48 /

-0.25 (-0.90%)

, MS

Morgan Stanley

$78.58 /

-2.31 (-2.86%)

, GS

Goldman Sachs

$342.30 /

+3.71 (+1.10%)

BMO Capital analyst James…

BMO Capital analyst James Fotheringham downgraded OneMain Holdings (OMF) to Market Perform from Outperform with an unchanged price target of $60. The analyst cites "exclusively" valuation for the downgrade. The shares have tripled over the past year and are now well above historical averages, Fotheringham tells investors in a research note. The analyst notes that he's not making a call on the upcoming quarter. He prefers market-oriented asset managers like KKR (KKR), Apollo Global (APO) , Franklin Resources (BEN), and Victory Capital (VCTR) as well as investment banks Morgan Stanley (MS) and Goldman Sachs (GS).

ShowHide Related Items >><<
VCTR Victory Capital
$27.48 /

-0.25 (-0.90%)

OMF OneMain Holdings
$55.96 /

+0.73 (+1.32%)

MS Morgan Stanley
$78.58 /

-2.31 (-2.86%)

KKR KKR
$53.29 /

+0.36 (+0.68%)

GS Goldman Sachs
$342.30 /

+3.71 (+1.10%)

BEN Franklin Resources
$30.05 /

-0.24 (-0.79%)

APO Apollo Global
$51.54 /

+1.27 (+2.53%)

OMF OneMain Holdings
$55.96 /

+0.73 (+1.32%)

04/15/21 JPMorgan
OneMain Holdings price target lowered to $64 from $65 at JPMorgan
02/11/21 Piper Sandler
OneMain secondary creates buying opportunity, says Piper Sandler
02/10/21 Northland
OneMain Holdings price target raised to $60 from $45 at Northland
02/10/21 Citi
OneMain Holdings price target raised to $62 from $45 at Citi
KKR KKR
$53.29 /

+0.36 (+0.68%)

04/14/21 BMO Capital
KKR price target raised to $71 from $69 at BMO Capital
04/14/21 Credit Suisse
KKR price target raised to $60 from $53 at Credit Suisse
04/14/21 Deutsche Bank
KKR price target raised to $52 from $47 at Deutsche Bank
04/14/21 Citi
Citi boosts KKR target to $65, removes from US Focus List
APO Apollo Global
$51.54 /

+1.27 (+2.53%)

04/14/21
Fly Intel: Top five analyst upgrades
04/14/21 Oppenheimer
Apollo Global upgraded to Outperform at Oppenheimer
04/14/21 Oppenheimer
Apollo Global upgraded to Outperform from Perform at Oppenheimer
04/12/21 Wells Fargo
Apollo Global price target lowered to $57 from $62 at Wells Fargo
BEN Franklin Resources
$30.05 /

-0.24 (-0.79%)

04/09/21 Deutsche Bank
Franklin Resources price target raised to $29 from $26 at Deutsche Bank
03/29/21 BMO Capital
Franklin Resources upgraded to Outperform from Market Perform at BMO Capital
01/28/21
Invesco upgraded to Buy from Neutral at UBS
01/25/21 Barclays
Franklin Resources price target raised to $24 from $21 at Barclays
VCTR Victory Capital
$27.48 /

-0.25 (-0.90%)

04/09/21 BofA
Victory Capital double-upgraded to Buy from Underperform at BofA
04/09/21 BofA
Victory Capital upgraded to Buy from Underperform at BofA
11/19/20
Fly Intel: Top five analyst downgrades
11/19/20 BofA
Victory Capital double-downgraded to Underperform from Buy at BofA
MS Morgan Stanley
$78.58 /

-2.31 (-2.86%)

04/16/21 Wells Fargo
Wells Fargo 'expected more' from Morgan Stanley after disclosing Archegos loss
04/09/21 JMP Securities
Goldman Sachs price target raised to $400 from $338 at JMP Securities
04/07/21 Barclays
Morgan Stanley price target raised to $98 from $95 at Barclays
04/01/21 Deutsche Bank
Morgan Stanley price target raised to $79 from $68 at Deutsche Bank
GS Goldman Sachs
$342.30 /

+3.71 (+1.10%)

04/16/21 BMO Capital
Goldman Sachs price target raised to $432 from $409 at BMO Capital
04/15/21 DA Davidson
Goldman Sachs price target raised to $378 from $347 at DA Davidson
04/15/21 Oppenheimer
Goldman Sachs price target raised to $497 from $468 at Oppenheimer
04/15/21 Credit Suisse
Goldman Sachs price target raised to $400 from $395 at Credit Suisse
VCTR Victory Capital
$27.48 /

-0.25 (-0.90%)

OMF OneMain Holdings
$55.96 /

+0.73 (+1.32%)

MS Morgan Stanley
$78.58 /

-2.31 (-2.86%)

KKR KKR
$53.29 /

+0.36 (+0.68%)

GS Goldman Sachs
$342.30 /

+3.71 (+1.10%)

BEN Franklin Resources
$30.05 /

-0.24 (-0.79%)

APO Apollo Global
$51.54 /

+1.27 (+2.53%)

  • 11
    Feb
  • 11
    Nov
MS Morgan Stanley
$78.58 /

-2.31 (-2.86%)

KKR KKR
$53.29 /

+0.36 (+0.68%)

GS Goldman Sachs
$342.30 /

+3.71 (+1.10%)

APO Apollo Global
$51.54 /

+1.27 (+2.53%)

MS Morgan Stanley
$78.58 /

-2.31 (-2.86%)

KKR KKR
$53.29 /

+0.36 (+0.68%)

GS Goldman Sachs
$342.30 /

+3.71 (+1.10%)

APO Apollo Global
$51.54 /

+1.27 (+2.53%)

VCTR Victory Capital
$27.48 /

-0.25 (-0.90%)

MS Morgan Stanley
$78.58 /

-2.31 (-2.86%)

GS Goldman Sachs
$342.30 /

+3.71 (+1.10%)

BEN Franklin Resources
$30.05 /

-0.24 (-0.79%)

APO Apollo Global
$51.54 /

+1.27 (+2.53%)

Saturday
On The Fly
Opening Day: Coinbase soars in market debut » 09:03
04/17/21
04/17
09:03
04/17/21
09:03
RXRX

Recursion Pharmaceuticals

$31.06 /

+0.81 (+2.68%)

, BMEA

Biomea Fusion

$18.48 /

-1.92 (-9.41%)

, AKYA

Akoya Biosciences

$26.92 /

+0.18 (+0.67%)

, APP

AppLovin

$61.01 /

-3.795 (-5.86%)

, AGL

Agilon Health

$30.45 /

-0.43 (-1.39%)

, KRT

Karat Packaging

$18.38 /

-0.52 (-2.75%)

, TSP

TuSimple

$39.99 /

+0.53 (+1.34%)

, EBET

Esports Technologies

$25.35 /

-10.69 (-29.66%)

, COIN

Coinbase

$341.27 /

+15.78 (+4.85%)

, ALKT

Alkami

$42.13 /

-0.13 (-0.31%)

, SQSP

Squarespace

/

+

, SVFD

Save Foods

/

+

, RGCB

Regencell Bioscience

/

+

, SWIM

Latham Group

/

+

, EDR

Endeavor

$41.49 /

+ (+0.00%)

, UBER

Uber

$60.34 /

-0.405 (-0.67%)

, LYFT

Lyft

$63.36 /

-1.07 (-1.66%)

Shares of Coinbase jumped…

ShowHide Related Items >><<
UBER Uber
$60.34 /

-0.405 (-0.67%)

LYFT Lyft
$63.36 /

-1.07 (-1.66%)

COIN Coinbase
$341.27 /

+15.78 (+4.85%)

RXRX Recursion Pharmaceuticals
$31.06 /

+0.81 (+2.68%)

BMEA Biomea Fusion
$18.48 /

-1.92 (-9.41%)

AKYA Akoya Biosciences
$26.92 /

+0.18 (+0.67%)

APP AppLovin
$61.01 /

-3.795 (-5.86%)

AGL Agilon Health
$30.45 /

-0.43 (-1.39%)

KRT Karat Packaging
$18.38 /

-0.52 (-2.75%)

TSP TuSimple
$39.99 /

+0.53 (+1.34%)

EBET Esports Technologies
$25.35 /

-10.69 (-29.66%)

COIN Coinbase
$341.27 /

+15.78 (+4.85%)

04/15/21 Loop Capital
Loop Capital starts Coinbase at Buy, sees 'lots of runway before takeoff'
04/15/21 Loop Capital
Coinbase initiated with a Buy at Loop Capital
04/15/21
Fly Intel: Top five analyst initiations
04/15/21 DA Davidson
Coinbase price target raised to $650 from $440 at DA Davidson
ALKT Alkami
$42.13 /

-0.13 (-0.31%)

SQSP Squarespace
/

+

SVFD Save Foods
/

+

RGCB Regencell Bioscience
/

+

SWIM Latham Group
/

+

EDR Endeavor
$41.49 /

+ (+0.00%)

UBER Uber
$60.34 /

-0.405 (-0.67%)

04/12/21 Truist
Uber's March update 'bodes well' for Q1 and FY21 outlook, says Truist
04/05/21 Evercore ISI
Uber assumed with an Outperform at Evercore ISI
04/01/21
Fly Intel: Top five analyst initiations
04/01/21 Jefferies
Uber initiated with a Buy at Jefferies
LYFT Lyft
$63.36 /

-1.07 (-1.66%)

04/05/21 Evercore ISI
Lyft assumed with an Outperform at Evercore ISI
03/31/21 Wolfe Research
Lyft assumed with a Peer Perform at Wolfe Research
03/26/21
Fly Intel: Top five analyst initiations
03/26/21 Vertical Research
Lyft initiated with a Buy at Vertical Research
UBER Uber
$60.34 /

-0.405 (-0.67%)

LYFT Lyft
$63.36 /

-1.07 (-1.66%)

COIN Coinbase
$341.27 /

+15.78 (+4.85%)

  • 23
    Apr
  • 14
    Apr
  • 15
    Apr
  • 16
    Apr
  • 16
    Apr
  • 16
    Apr
  • 15
    Apr
  • 15
    Apr
  • 15
    Apr
  • 14
    Apr
  • 15
    Apr
  • 08
    Jan
UBER Uber
$60.34 /

-0.405 (-0.67%)

TSP TuSimple
$39.99 /

+0.53 (+1.34%)

LYFT Lyft
$63.36 /

-1.07 (-1.66%)

COIN Coinbase
$341.27 /

+15.78 (+4.85%)

UBER Uber
$60.34 /

-0.405 (-0.67%)

SQSP Squarespace
/

+

LYFT Lyft
$63.36 /

-1.07 (-1.66%)

EBET Esports Technologies
$25.35 /

-10.69 (-29.66%)

COIN Coinbase
$341.27 /

+15.78 (+4.85%)

AGL Agilon Health
$30.45 /

-0.43 (-1.39%)

UBER Uber
$60.34 /

-0.405 (-0.67%)

LYFT Lyft
$63.36 /

-1.07 (-1.66%)

Friday
On The Fly
Bet On It: Arizona legalizes sports betting, while Maryland nears finish line » 16:03
04/16/21
04/16
16:03
04/16/21
16:03
DKNG

DraftKings

$57.96 /

+0.465 (+0.81%)

, CZR

Caesars

$93.59 /

+0.4 (+0.43%)

, PDYPY

Flutter Entertainment

$109.10 /

+3.03 (+2.86%)

, BALY

Bally's

$58.60 /

+1.1 (+1.91%)

, JKPTF

Gamesys Group

$26.80 /

+0.3 (+1.13%)

, LVS

Las Vegas Sands

$61.09 /

-0.21 (-0.34%)

, ACEL

Accel Entertainment

$11.87 /

+0.18 (+1.54%)

, BYD

Boyd Gaming

$65.85 /

+0.73 (+1.12%)

, CHDN

Churchill Downs

$220.43 /

+3.02 (+1.39%)

, GAN

Gan Limited

$18.29 /

+0.3 (+1.67%)

, MGM

MGM Resorts

$40.25 /

+0.57 (+1.44%)

, PENN

Penn National

$99.86 /

-0.81 (-0.80%)

, SGMS

Scientific Games

$47.37 /

+2.46 (+5.48%)

, SCR

Score Media

$21.05 /

+2.3 (+12.27%)

, WIMHY

William Hill

$15.12 /

+0.14 (+0.93%)

, WYNN

Wynn Resorts

$127.47 /

-0.43 (-0.34%)

, RSI

Rush Street Interactive

$14.39 /

+0.06 (+0.42%)

Welcome to the latest…

ShowHide Related Items >><<
WYNN Wynn Resorts
$127.47 /

-0.43 (-0.34%)

SGMS Scientific Games
$47.37 /

+2.46 (+5.48%)

RSI Rush Street Interactive
$14.39 /

+0.06 (+0.42%)

PENN Penn National
$99.86 /

-0.81 (-0.80%)

PDYPY Flutter Entertainment
$109.10 /

+3.03 (+2.86%)

MGM MGM Resorts
$40.25 /

+0.57 (+1.44%)

LVS Las Vegas Sands
$61.09 /

-0.21 (-0.34%)

JKPTF Gamesys Group
$26.80 /

+0.3 (+1.13%)

GAN Gan Limited
$18.29 /

+0.3 (+1.67%)

DKNG DraftKings
$57.96 /

+0.465 (+0.81%)

CZR Caesars
$93.59 /

+0.4 (+0.43%)

CHDN Churchill Downs
$220.43 /

+3.02 (+1.39%)

BYD Boyd Gaming
$65.85 /

+0.73 (+1.12%)

BALY Bally's
$58.60 /

+1.1 (+1.91%)

ACEL Accel Entertainment
$11.87 /

+0.18 (+1.54%)

DKNG DraftKings
$57.96 /

+0.465 (+0.81%)

04/07/21 Truist
Truist sees NY budget agreement's mobile sports betting deal as 'clear as mud'
04/06/21 Credit Suisse
Reports, contacts point to sports betting momentum in NY, Credit Suisse says
04/01/21 Credit Suisse
NY online sports betting likely to make it into budget, says Credit Suisse
03/30/21 Loop Capital
Loop Capital recommends buying DraftKings going into NY budget deadline
CZR Caesars
$93.59 /

+0.4 (+0.43%)

04/08/21 KeyBanc
Caesars price target raised to $110 from $102 at KeyBanc
04/05/21
Fly Intel: Top five analyst upgrades
PDYPY Flutter Entertainment
$109.10 /

+3.03 (+2.86%)

04/12/21 RBC Capital
Flutter price target raised to 17,000 GBp from 15,700 GBp at RBC Capital
03/30/21 Barclays
Flutter price target raised to 17,500 GBp from 15,000 GBp at Barclays
BALY Bally's
$58.60 /

+1.1 (+1.91%)

04/08/21 KeyBanc
Bally's price target raised to $70 from $65 at KeyBanc
03/29/21 Truist
Early March casino data looks 'very positive,' says Truist
03/25/21 Stifel
Bally's price target raised to $75 from $70 at Stifel
03/24/21 Jefferies
Gamesys Group and Bally's an 'interesting combination,' says Jefferies
JKPTF Gamesys Group
$26.80 /

+0.3 (+1.13%)

04/14/21 Canaccord
Gamesys Group downgraded to Hold on merger at Canaccord
04/14/21 Canaccord
Gamesys Group downgraded to Hold from Buy at Canaccord
03/16/21 Jefferies
Gamesys Group price target raised to 2,150 GBp from 1,930 GBp at Jefferies
LVS Las Vegas Sands
$61.09 /

-0.21 (-0.34%)

03/29/21 Deutsche Bank
New York may be 'kicking the can' on sports betting, says Deutsche
03/18/21 JPMorgan
Micro-betting market in U.S. 'could be substantial,' says JPMorgan
ACEL Accel Entertainment
$11.87 /

+0.18 (+1.54%)

04/08/21 JPMorgan
Accel Entertainment initiated with an Overweight at JPMorgan
03/16/21 Deutsche Bank
Accel Entertainment price target raised to $13 from $12 at Deutsche Bank
03/08/21 Macquarie
Accel Entertainment initiated with a Neutral at Macquarie
03/08/21 Macquarie
Accel Entertainment initiated with a Neutral at Macquarie
BYD Boyd Gaming
$65.85 /

+0.73 (+1.12%)

04/16/21 Deutsche Bank
Boyd Gaming price target raised to $71 from $67 at Deutsche Bank
04/08/21 KeyBanc
Boyd Gaming price target raised to $69 from $61 at KeyBanc
04/05/21 Morgan Stanley
Caesars upgraded to Overweight from Equal Weight at Morgan Stanley
CHDN Churchill Downs
$220.43 /

+3.02 (+1.39%)

03/01/21 KeyBanc
Churchill Downs price target raised to $250 from $239 at KeyBanc
02/09/21 Morgan Stanley
Morgan Stanley says legalized sports betting in Texas this year has 'slim' odds
GAN Gan Limited
$18.29 /

+0.3 (+1.67%)

03/26/21
Fly Intel: Top five analyst downgrades
03/26/21 Craig-Hallum
Gan Limited downgraded to Hold from Buy at Craig-Hallum
MGM MGM Resorts
$40.25 /

+0.57 (+1.44%)

04/05/21 Morgan Stanley
Morgan Stanley upgrades MGM Resorts to Overweight after Vegas visit
PENN Penn National
$99.86 /

-0.81 (-0.80%)

SGMS Scientific Games
$47.37 /

+2.46 (+5.48%)

03/04/21 Credit Suisse
Scientific Games price target raised to $35 from $9 at Credit Suisse
02/09/21 Craig-Hallum
Scientific Games Digital segment still 'underappreciated,' says Craig-Hallum
01/19/21 Jefferies
Scientific Games price target raised to $55 from $50 at Jefferies
01/14/21 Truist
Scientific Games price target raised to $60 from $45 at Truist
SCR Score Media
$21.05 /

+2.3 (+12.27%)

03/23/21 Credit Suisse
Score Media initiated with an Outperform at Credit Suisse
03/22/21 Macquarie
Score Media initiated with an Outperform at Macquarie
WIMHY William Hill
$15.12 /

+0.14 (+0.93%)

WYNN Wynn Resorts
$127.47 /

-0.43 (-0.34%)

04/06/21
Fly Intel: Top five analyst upgrades
04/06/21 Argus
Wynn Resorts upgraded to Buy from Hold at Argus
RSI Rush Street Interactive
$14.39 /

+0.06 (+0.42%)

04/16/21
Fly Intel: Top five analyst initiations
04/16/21 Jefferies
Jefferies starts Rush Street Interactive at Buy with $21 price target
04/16/21 Jefferies
Rush Street Interactive initiated with a Buy at Jefferies
WYNN Wynn Resorts
$127.47 /

-0.43 (-0.34%)

SGMS Scientific Games
$47.37 /

+2.46 (+5.48%)

RSI Rush Street Interactive
$14.39 /

+0.06 (+0.42%)

PENN Penn National
$99.86 /

-0.81 (-0.80%)

MGM MGM Resorts
$40.25 /

+0.57 (+1.44%)

LVS Las Vegas Sands
$61.09 /

-0.21 (-0.34%)

GAN Gan Limited
$18.29 /

+0.3 (+1.67%)

DKNG DraftKings
$57.96 /

+0.465 (+0.81%)

CZR Caesars
$93.59 /

+0.4 (+0.43%)

CHDN Churchill Downs
$220.43 /

+3.02 (+1.39%)

BYD Boyd Gaming
$65.85 /

+0.73 (+1.12%)

BALY Bally's
$58.60 /

+1.1 (+1.91%)

ACEL Accel Entertainment
$11.87 /

+0.18 (+1.54%)

  • 16
    Apr
  • 25
    Feb
  • 09
    Feb
  • 17
    Dec
  • 07
    Oct
  • 29
    Sep
  • 25
    Sep
  • 24
    Sep
  • 19
    Jun
  • 12
    May
  • 05
    May
WYNN Wynn Resorts
$127.47 /

-0.43 (-0.34%)

SCR Score Media
$21.05 /

+2.3 (+12.27%)

PDYPY Flutter Entertainment
$109.10 /

+3.03 (+2.86%)

LVS Las Vegas Sands
$61.09 /

-0.21 (-0.34%)

DKNG DraftKings
$57.96 /

+0.465 (+0.81%)

CZR Caesars
$93.59 /

+0.4 (+0.43%)

BYD Boyd Gaming
$65.85 /

+0.73 (+1.12%)

BALY Bally's
$58.60 /

+1.1 (+1.91%)

WYNN Wynn Resorts
$127.47 /

-0.43 (-0.34%)

LVS Las Vegas Sands
$61.09 /

-0.21 (-0.34%)

JKPTF Gamesys Group
$26.80 /

+0.3 (+1.13%)

GAN Gan Limited
$18.29 /

+0.3 (+1.67%)

DKNG DraftKings
$57.96 /

+0.465 (+0.81%)

CZR Caesars
$93.59 /

+0.4 (+0.43%)

BYD Boyd Gaming
$65.85 /

+0.73 (+1.12%)

BALY Bally's
$58.60 /

+1.1 (+1.91%)

WYNN Wynn Resorts
$127.47 /

-0.43 (-0.34%)

SGMS Scientific Games
$47.37 /

+2.46 (+5.48%)

SCR Score Media
$21.05 /

+2.3 (+12.27%)

RSI Rush Street Interactive
$14.39 /

+0.06 (+0.42%)

PENN Penn National
$99.86 /

-0.81 (-0.80%)

MGM MGM Resorts
$40.25 /

+0.57 (+1.44%)

LVS Las Vegas Sands
$61.09 /

-0.21 (-0.34%)

GAN Gan Limited
$18.29 /

+0.3 (+1.67%)

DKNG DraftKings
$57.96 /

+0.465 (+0.81%)

CZR Caesars
$93.59 /

+0.4 (+0.43%)

BYD Boyd Gaming
$65.85 /

+0.73 (+1.12%)

Options
Nordstrom put volume heavy and directionally bearish » 11:35
04/16/21
04/16
11:35
04/16/21
11:35
JWN

Nordstrom

$35.33 /

-0.58 (-1.62%)

Bearish flow noted in…

Bearish flow noted in Nordstrom with 1,260 puts trading, or 1.3x expected. Most active are May-21 32.5 puts and Apr-21 30 puts, with total volume in those strikes near 460 contracts. The Put/Call Ratio is 2.36, while ATM IV is up over 5 points on the day. Earnings are expected on May 27th.

ShowHide Related Items >><<
JWN Nordstrom
$35.33 /

-0.58 (-1.62%)

JWN Nordstrom
$35.33 /

-0.58 (-1.62%)

03/12/21
Fly Intel: Top five analyst initiations
03/12/21 Jefferies
Jefferies picks Macy's, Kohl's and Nordstrom as department store 'survivors'
03/12/21 Jefferies
Nordstrom initiated with a Buy at Jefferies
02/16/21 JPMorgan
Nordstrom price target raised to $40 from $34 at JPMorgan
JWN Nordstrom
$35.33 /

-0.58 (-1.62%)

JWN Nordstrom
$35.33 /

-0.58 (-1.62%)

JWN Nordstrom
$35.33 /

-0.58 (-1.62%)

JWN Nordstrom
$35.33 /

-0.58 (-1.62%)

Hot Stocks
General Motors, LG Energy Solution investing $2.3B in U.S. manufacturing plant » 10:02
04/16/21
04/16
10:02
04/16/21
10:02
GM

General Motors

$58.71 /

+0.1 (+0.17%)

Ultium Cells LLC, a joint…

Ultium Cells LLC, a joint venture of LG Energy Solution and General Motors, announced a more than $2.3B investment to build its second battery cell manufacturing plant in the United States. The facility will be located in Spring Hill, Tennessee. Ultium Cells will build the new plant on land leased from GM. The new battery cell plant will create 1,300 new jobs. Construction on the approximately 2.8 million-square-foot facility will begin immediately, and the plant is scheduled to open in late 2023. Once operational, the facility will supply battery cells to GM's Spring Hill assembly plant. The Spring Hill plant will use the most advanced and efficient battery cell manufacturing processes. The plant will be extremely flexible and able to adapt to ongoing advances in technology and materials.

ShowHide Related Items >><<
GM General Motors
$58.71 /

+0.1 (+0.17%)

GM General Motors
$58.71 /

+0.1 (+0.17%)

04/14/21 Evercore ISI
General Motors price target raised to $65 from $62 at Evercore ISI
04/05/21
Fly Intel: Top five analyst initiations
04/05/21 Wells Fargo
General Motors initiated with an Overweight at Wells Fargo
03/29/21 Jefferies
General Motors price target raised to $62 from $50 at Jefferies
GM General Motors
$58.71 /

+0.1 (+0.17%)

GM General Motors
$58.71 /

+0.1 (+0.17%)

GM General Motors
$58.71 /

+0.1 (+0.17%)

GM General Motors
$58.71 /

+0.1 (+0.17%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.